Efficacy and Safety of Hepatitis B Vaccine in Chronic Kidney Disease Patients

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT01933412

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01933412
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
Not reported
Countries
Israel (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01933412. Randomized; no masking; primary purpose prevention. Start 2012-03 (registry gives no type); primary completion 2013-08 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of Hepatitis B Vaccine in Chronic Kidney Disease Patients
Condition
Hepatitis B
Intervention (Biological)
Sci-B-Vac Hepatitis B Vaccine
Intervention (Biological)
Engerix B Hepatitis B Vaccine
Lead sponsor
Tel-Aviv Sourasky Medical Center (class: other government)

Record details

Record id
cardio:ct-nct01933412
Content hash
6c7d709a73852e894869f960106e7cc70164516e6a63b981fb23f262d78640d6